Supreme Court rules generic drug makers cannot be held liable for defects

By Reuters
Monday, June 24, 2013 10:34 EDT
google plus icon
Pills (AFP)
  • Print Friendly and PDF
  • Email this page

WASHINGTON (Reuters) – The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects.

In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of URL Pharma, owned by Sun Pharmaceutical Industries.

(Reporting by Lawrence Hurley; Editing by Howard Goller and Will Dunham)

Reuters.com brings you the latest news from around the world, covering breaking news in business, politics, technology, and more.
By commenting, you agree to our terms of service
and to abide by our commenting policy.